The Ebola outbreak in the Democratic Republic of Congo continues to spread at an unprecedented rate, claiming more than 3,000 lives and infecting over 6,100 people since it was declared a global health emergency in mid-May. The latest figures from Congo's Ministry of Health indicate 6,186 confirmed cases, including 3,007 fatalities. This outbreak has become the fastest-growing and deadliest in the country's history.
Recent weeks have seen a significant increase in new cases, with two additional health zones in North Kivu province reporting infections. This region has a notably higher fatality rate compared to other affected areas. The virus has now spread across six provinces.
Efforts to contain the disease are hampered by challenging conditions, including multiple strikes by health workers demanding unpaid wages. The rapid transmission is attributed to several compounding factors, such as ongoing conflict in the eastern region where the outbreak is concentrated, attacks targeting health workers, the frequent movement of miners, and insufficient health infrastructure.
The resumption of school activities amidst the outbreak has also raised concerns about potential transmission within classrooms.
The World Health Organization has warned that the current outbreak is on track to surpass the severity of the West Africa outbreak between 2014 and 2016, which resulted in 11,000 deaths. The Africa Center for Disease Control and Prevention estimates that the actual number of cases could be three times higher than officially recorded, due to weaknesses in surveillance and contact tracing.
Currently, there is no vaccine or approved treatment for the specific Bundibugyo virus strain responsible for this outbreak. However, development of new vaccines is underway. The Congolese government is distributing the Ervebo vaccine, which has proven effective in combating previous Ebola outbreaks and may offer some protection against the current strain, according to the WHO.